EN
HI
Cohance Lifesciences Share price
COHANCE
995.8
15.75 (-1.56%)NSE
BSE
Last updated on 30 Jul, 2025 | 15:29 IST
BUYSELL
Today's High
1020.00
Today's Low
995.00
52 Week Low
888.55
52 Week High
1360.00
The current prices are delayed, login to your account for live prices
LoginCohance Lifesciences Chart
Cohance Lifesciences Share Key Metrics
Volume
30739.00
Market Cap
38698.58 CR
LTQ@LTP
27@995.80
ATP
1003.61
Var Margin
17.91 %
Circuit Range
809.25-1213.85
Delivery %
48.16 %
Value
3.08 CR
ASM/GSM
No
Market Lot
1
Cohance Lifesciences Corporate Actions
| Date | Agenda | |
|---|---|---|
| 2025-08-13 | Quarterly Results | |
| 2025-05-28 | Audited Results | |
| 2025-02-12 | Quarterly Results | |
| Date | Record Date | ||
|---|---|---|---|
 | |||
Cohance Lifesciences News
National Company Law Tribunal clears Casper Pharma’s merger with Suven Pharmaceuticals
Oct 30 2024 05:57:11
Read More
About Cohance Lifesciences
NSE : 17945
BSE : 543064
ISIN : INE03QK01018
Cohance Lifesciences Management
| Name | Position |
|---|---|
| Mr. Annaswamy Vaidheesh | Executive Chairperson |
| Dr. V Prasada Raju | Managing Director |
| Mr. Pankaj Patwari | Non Executive Director |
| Ms. Shweta Jalan | Non Executive Director |
| Ms. Matangi Gowrishankar | Independent Director |
Cohance Lifesciences Similar Stocks
Glaxosmithkline Pharmaceuticals Ltd.
3190.00
39.80 (1.26%)
Biocon Ltd.
397.30
-0.85 (0.21%)
Laurus Labs Ltd.
881.45
-28.40 (3.12%)
Anthem Biosciences Ltd.
770.65
-11.80 (1.51%)
Narayana Hrudayalaya Ltd.
1937.80
-44.80 (2.26%)
Ipca Laboratories Ltd.
1529.50
41.00 (2.75%)
Global Health Ltd.
1306.30
-25.10 (1.89%)
Ajanta Pharma Ltd.
2800.50
-22.70 (0.80%)
Gland Pharma Ltd.
2060.70
-41.40 (1.97%)
Krishna Institute of Medical Sciences Ltd
750.45
0.60 (0.08%)
Cohance Lifesciences FAQs
The Buying Price of Cohance Lifesciences share is 995.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Cohance Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Cohance Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Cohance Lifesciences shares is 142.33. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Cohance Lifesciences shares is 22.3. Useful to assess the stock's value relative to its book value.
To assess Cohance Lifesciences’s valuation compare Sector P/E, P/B which are 35.47 & 3.86 with sector averages, along with growth rates and financial metrics.
The Market Cap of Cohance Lifesciences is 38698.58 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Cohance Lifesciences share price is 1360.00 & 888.55. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.